Abstract. Bacillus Calmette-Guérin (BCG) immunotherapy is the standard therapy for non-muscle invasive bladder cancer. The aim of the present study was to identify genes that are induced in response to BCG immunotherapy, as these may be potential biomarkers for the response to clinical therapy. To model clinical therapy, human bladder cancer cell lines were incubated with BCG (live or lyophilized BCG Connaught) for 2 h. RNA was extracted and evaluated by Representational Differential Analysis (RDA) and oligo arrays. Gene expression was confirmed by reverse transcription polymerase chain reaction on fresh cell lines with differential abilities to internalize BCG. The effect of 2 major BCG soluble proteins, antigen 85B (Ag85B) and Mycobacterium protein tyrosine phosphatase A (MptpA) and BCG Tice ® on gene expression was also determined. GAPDH and β-actin, which are normally used as control genes, were upregulated by BCG. Therefore, the ribosomal RNA gene ribosomal protein S27a was used to normalize gene expression. The genes likely to be induced by BCG internalization and soluble factors were: GSTT2, MGST2, CCL20, TNFα, CCNE1 and IL10RB. Those induced by BCG membrane interactions and/or soluble factors were: MGST1, CXCL6, IL12A, CSF2, IL1β and TOLLIP. MptpA decreased GSTT2 expression, and Ag85B increased TNFα expression. The two BCG strains significantly increased GSTT2, TNFα and TOLLIP levels in MGH cells. However, in J82 cells there was a BCG strain-dependent difference in TNFα expression. An important outcome of the present study was the determination that neither GAPDH nor β-actin were suitable control genes for the analysis of BCG-induced gene expression. BCG Connaught and Tice ® induced similar expression levels of genes in bladder cancer cell lines. BCG soluble proteins modulated gene expression and therefore may affect therapeutic outcomes. The genes identified may be novel biomarkers of the response to BCG therapy.
Introduction
The standard treatment for non-muscle invasive bladder cancer is transurethral resection of the tumor (TUR) followed by intravesical instillation of lyophilized Bacillus Calmette-Guérin (BCG) (1) . BCG induces a non-specific immune response that is believed to remove remnant tumor cells (1) and direct BCG interaction with cancer cells may have a role in this response (2) .
BCG is internalized by bladder cancer cells via the α5β1 integrin complex (3) , and cross-linking of this receptor by BCG induces gene expression (4) . The internalization process occurs via micropinocytosis (5) , as opposed to phagocytosis. BCG internalization is associated with decreased production of reactive oxygen species (ROS) and thiols (6) and increased cell death. BCG-induced cell death has been revealed to be associated with NO production (7) , and is necrotic, involving the release of HMGB1, which exhibits paracrine effects on urothelial cells (8) .
Lyophilized and live BCG induce differential ROS modulation in A549 lung epithelial cancer cells (9) and human bladder cancer cell lines (10) , probably as lyophilized preparations contain extruded cellular components, secreted BCG proteins and whole bacteria. Similarly, intravesical instillation of live and inactivate BCG preparations in mice induced differential cytokine/chemokine gene expression (11) .
The present study further elucidates the cellular changes induced by BCG interaction with cancer cells in the clinical time-frame of 2 h. In this time frame, RNA expression changes are easily detected compared with changes in protein levels. A stimulated cell may trigger novel mRNA synthesis within a few min, but protein production requires a longer time period. The genes induced within 2 h will generate proteins that will in turn lead to the expression of other genes. Therefore, studies evaluating expression at time points beyond 2 h are examining primary, secondary or even tertiary responses to the original stimulus. Genes whose expression is triggered immediately following interaction with BCG may be specific markers of the response to BCG immunotherapy.
Bacillus Calmette-Guérin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival
JUWITA N. RAHMAT 1 , KESAVAN ESUVARANATHAN 1,2 and RATHA MAHENDRAN Several BCG strains are used to treat bladder cancer. Genetic analyses have indicated that these strains have genetic differences (12, 13 ) that affect their anti-proliferative effects on human bladder cancer cell lines. Therefore, the ability of the two most commonly used BCG strains, namely BCG Connaught and Tice, to modulate gene expression was compared. It was hypothesized that genes induced by these similar strains are likely to be important for the response of cells to BCG.
To evaluate gene expression changes, human bladder cancer cell lines with known differential ability to internalize BCG (14) were exposed to BCG for 2 h in the present study. This allowed differentiation between responses induced by BCG internalization, and identification of those responses likely to be induced by membrane interactions. The effect of major BCG soluble proteins Ag85B and Mycobacterium protein tyrosine phosphatase A (MptpA) on gene expression was also determined. RNA was extracted from these cells, subjected to the representational differential analysis (RDA) (15) and used to probe oligo arrays to identify differentially expressed genes.
Materials and methods

Preparation of bacteria.
Lyophilized BCG strains [(Connaught; Sanofi S.A., Paris, France) and Tice (Merck Sharp & Dohme, Whitehouse Station, NJ, USA)] were prepared as previously described (10) . BCG was maintained in 7H9 Middlebrook media (Difco™; BD Biosciences, Franklin, NJ, USA) supplemented with 10% ADC supplement (0.85% NaCl, 5% bovine serum albumin fraction V, 2% dextrose and 0.003% catalase; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), 0.05% Tween-80 and 0.2% glycerol. Live Connaught BCG was grown on 7H10 Middlebrook agar supplemented with 10% ADC supplement, 0.05% Tween-80 and 0.5% glycerol, and single colonies were selected for growth. BCG cultures were harvested at 0.7 to 0.8 OD 600nm at the exponential phase. The formula OD 600nm 0.1=2.6x10 6 colony forming units (c.f.u.)/ml was established by plating serial dilutions of BCG culture on 7H10 Middlebrook agar with supplements.
Mammalian cell culture. Human transitional cell carcinoma cell lines MGH, RT4 and J82 (American Type Culture Collection, Manassas, VA, USA) were cultured in RPMI (Biowest, Nuaillé, France) supplemented with 10% heat inactivated fetal bovine serum (Biowest), 2 mM L-glutamine, 50 U/ml penicillin G and 50 µg/ml streptomycin at 37˚C in 5% CO 2 and routinely passaged when 85-90% confluent. The cells (2x10 6 ) plated overnight were incubated with 2x10 7 cfu live or lyophilized BCG at 37˚C for 2 h. A Transwell device blocked direct contact between BCG and the cells. Sodium orthovandate (100 µM) inhibited tyrosine phosphatase activity. Purified MptpA at 0.5 µg/ml and 5 µg/ml, prepared as described previously (10) , was added to the cells at 37˚C for 2 h, and RNA was isolated. Ag85B (Sigma-Aldrich; Merck KGaA) at a concentration of 1 µg/ml was added to the cells. For verification of gene expression, the experiments were performed three times in duplicate.
RNA extraction and RDA. MGH (6x10 5 ) cells were plated in a 10 mm cell culture dish overnight prior to treatment with 6x10 7 cfu of lyophilized BCG at 37˚C for 2 h. Total RNA was extracted using TRIzol ® (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Then, poly A + RNA was isolated using the Oligotex ® mRNA midi kit (Qiagen, Inc., Valencia, CA, USA) and converted to cDNAs with Riboclone ® cDNA Synthesis system (Promega Corporation, Madison, WI, USA), according to the manufacturer's protocols. The RDA was performed as described by Pastorian et al (15) . The samples with and without BCG treatment were subjected to repeated rounds of subtractive hybridization at 1:10, 1:100 and 1:5,000 tester to driver ratios. Only products that were upregulated in the tester population were amplifiable by polymerase chain reaction (PCR). The PCR amplified products were ligated into pGEM ® T Easy Vector (Promega Corporation), transformed into DH5α cells and positive clones were selected on LB agar plates with 100 µg/ml ampicillin. Plasmid DNA was isolated (Promega Corporation) and sequenced with-21M13 forward primers (5'-GTA AAA CGA CGG CCA GT-3') using the BigDye version 3.0 system (Applied Biosystems; Thermo Fisher Scientific, Inc.). The sequencing results were identified using the BLAST algorithm (https://blast.ncbi.nlm.nih. gov/Blast.cgi).
Expression array analysis.
PolyA + mRNA samples were converted to Biotin-16-UTP (Roche Diagnostics, Indianapolis, IN, USA) labeled cRNA using the TrueLabelling-AMP™ Linear RNA Amplification kit (SABiosciences, Frederick, MD, USA). The labeled cRNA was purified from interfering free Biotin-16-UTP using the Array Grade cRNA Cleanup kit (SABiosciences). The yield of cRNA samples were quantified using the formula as follows: Concentration (µg/ml)=OD260x40 x dilution factor (dilution factor, 350). The Inflammatory Cytokines and Receptors and Toxicology and Drug Resistance microarray (OHS401, SABiosciences) was assayed as previously described (16) . Chemiluminescence detection was performed using the SABiosciences Chemiluminescent Detection Kit and X-ray films. Blot intensity analysis was performed using SABiosciences GEArray Expression Analysis Suite online software (http://saweb2. sabiosciences.com/support_software.php).
Reverse transcription (RT-PCR.
A total of ~5 µg of RNA was pre-treated with 1 U DNAse in 1X DNAse buffer (20 mM Tris. Cl pH 8.4, 20 mM MgCl 2 , 500 mM KCl) and 40 U RNAsin for 15 min at room temperature, and digestion was terminated by the addition of EDTA (final concentration, 2.5 mM). Oligo dT (0.5 µg) was added, and the mixture was incubated at 65˚C for 10 min, then chilled on ice for 5 min prior to the addition of the cDNA synthesis buffer (50 mM Tris pH 8.3, 75 mM KCl, 3 mM MgCl 2 ), 0.5 mM dNTPs (Promega Corporation), 8 U RNAsin (Promega Corporation), 200 U SuperScript II enzyme (Invitrogen; Thermo Fisher Scientific, Inc.) and incubation at 42˚C for 50 min. The reaction was terminated by heating at 70˚C for 15 min, and then the samples were diluted with 180 µl TE buffer (20 mM Tris pH 8.0, 1 mM EDTA). PCR was performed on cDNAs (5 µl) with 0.5 µM gene-specific primers, 0.2 mM dNTPs, 0.5 U DyNAzyme™ DNA polymerase (Finnzymes; Thermo Fisher Scientific, Inc.) in 10 mM Tris pH 8.8, 50 mM KCl, 1.5 mM MgCl 2 and 0.1% Triton ® X-100. The PCR products were separated on a 1.5% agarose gel, and the relative density of the gene-specific PCR products and ribosomal protein S27a (RPS27A) was determined using the GeneTools densitometry software (version 3.0; Syngene Europe, Cambridge, UK). Gene expression data is presented as the mean ± standard error. Table I lists the sequences of the PCR primers, annealing temperature and size of the PCR products. The thermocycling conditions comprise one initial denaturation step at 94˚C for 5 min followed by repeated amplification cycles of 94˚C, primer annealing temperature and 72˚C for 30 sec each and one final extension step at 72˚C for 5 min. The appropriate number of PCR cycles for each primer set was determined by plotting the density of the PCR products at 30, 35 and 40 cycles. For the majority of the genes, 30 and 35 cycles were suitable for differential expression analysis.
Statistical analysis. For analysis between two or more samples, one-way analysis of variance with post hoc Bonferroni test was used. Independent sample t-tests were used for comparisons between two samples. P<0.05 was considered to indicate a statistically significant difference.
Results
GAPDH and β-actin are induced by BCG in bladder cancer cells. MGH cells, which readily internalize BCG, were exposed to BCG Connaught for 2 h, and the RNA was extracted and subjected to several rounds of subtractive hybridization. The RNA was subsequently cloned and sequenced following the protocol developed by Pastorian et al (15) . A total of 56 clones were isolated (from control and BCG treated samples) and sequenced. The sequences were identified by using the BLAST program on GenBank. The genes identified are listed in Table II . A total of 6 genes were chosen for validation by RT-PCR on fresh samples, but only 2 genes (β-actin and GAPDH) were confirmed to be induced in MGH and RT4 cells exposed to lyophilized and live BCG (Fig. 1) . The other genes identified: Glutathione-S-transferase κ; heat shock protein 70 protein 5; natural killer cell enhancing factor; and β1 integrin, were not differentially modulated. As RT4 cells do not internalize BCG as well compared with MGH cells (10), the gene expression changes induced in RT4 cells may be due to membrane signaling or the uptake of BCG soluble factors. TNFα  GTGTGGCCTGCACAGTGA  GGAGCAGAGGCTCAGCAA  56  550  IL1β  ACATGCCCGTCTTCCTGG  GGGAAGCGGTTGCTCATC  56  421  TOLLIP  GGACAGGCTTGTCTGCCA  CGCACGTTCTGAGACCAC  56  317  CCL20  GCCAATGAAGGCTGTGAC  ACAAGTCCAGTGAGGCAC  54  262  CSF2  CAGGAGCCGACCTGCCTA  TCAGGGTCAGTGTGGCCC  58  388  IL10RB  CCTTAGAGGTCGAGGCAG  GTCCGTGCTCTGTGTAGC  56  420  CXCL6  CCAGTCTTCAGCGGAGCA  CCTCCCTCAACAGCACAC  54  384  IL12A  AATGGGAGTTGCCTGGCC  ACGGTTTGGAGGGACCTC  56  364  CXCL5  GGACCAGAGAGAGCTTGG  GTGTGTCCCACCAGGACT  56  373  IL11RA  TCTGGCTGAGGCTGAGAC  TCCCTGCCTCACAGACAC  56  370  IL15RA  AGCTTCCCAGGAGAGACC  TCCCAGGTCCCTGTCCAT  56  279  SCYE1  TGGAGAGAGGAAGTTGCC  GTCAGGGTTACTCTGGCA  54  357  GSTA3  ATGGACGGGGCAGAATGG  GGAGATAAGGCTGGAGTC  54  497  GSTT2  AGGCTCGTGCCCGTGTTC  GGCCTCTGGTGAGGGTG  58  428  GSTM5  CAGAAGATGGGAGGGAGG  GGGGGACTTTGATGGAGG  56  207  MGST1  GCAGAGCCCACCTGAATG  TCCTCTGCTCCCCTCCTA  56  354  MGST2  AGACCTGCCTGCCTTCCT  CCACCCAGCCATCCACAA  56  392  HSPA6  CAGTGGCATCCCTCCTGC  GCGGGCTTGAGTGCCACA  58  499  NOS2A  CCTGGCAAGCCCAAGGTC  CACCCACTTGCCAGGCCT  58  587  NAT2  GTGACCATTGACGGCAGG  CGTGAGGGTAGAGAGGAT  54  630  NAT5  CCTTTACCTGCGACGACC  GGAGGAGACTGGAGCAAG  56  830   β-ACTIN   AAATCGTGCGTGACATTAAGG  AGCACTGTGTTGGCGTACAG  50  277  GAPDH  GGAAGGACTCATGACCAC  GGTCTCTCTCTTCCTCTT  53  546  RPS27A  CTCGAGGTTGAACCCTCG  GCACTCTCGACGAAGGCG  56  321 TNF, tumor necrosis factor; IL, interleukin; TOLLIP, Toll interacting protein; CCL20, C-C motif chemokine ligand 20; CSF2, colony stimulating factor 2; CXCL, C-X-C motif chemokine ligand; IL11RA, Interleukin 11 receptor subunit α; IL15RA, interleukin 15 receptor subunit α; SCYE1, ARS-interacting multifunctional protein 1; GSTA3, glutathione S-transferase α3; GSTT2, glutathione S-transferase θ2; GSTM5, glutathione S-transferase µ5; MGST, microsomal glutathione S-transferase; HSPA6, heat shock protein family A (Hsp70) member 6; NOS2A, nitric oxide synthase 2; NAT2, N-acetyltransferase 2; NAT5, N(alpha)-acetyltransferase 20, NatB catalytic subunit; RPS27A, ribosomal protein S27a.
β-actin and GAPDH are normally used as controls for gene expression analysis, and normalization with these genes would lead to erroneous interpretation of gene expression changes. A ribosomal protein gene, RPS27A, was identified not to vary in response to BCG and was used as a control gene (Fig. 1) . One limitation of the RDA strategy was that often the sequence identified had homology to a conserved domain of a family of associated genes, which meant it was difficult to identify the actual family member that was induced. Therefore, oligo arrays with detoxification genes and inflammatory cytokine genes were also analyzed.
Live and lyophilized BCG induced differential gene expression.
Several genes were identified to be differentially expressed on the arrays following exposure of MGH cells to live or lyophilized BCG (Fig. 2) + mRNA harvested from each sample was converted to biotin labeled cRNA, which were then used to probe the inflammatory cytokines and receptors, and toxicology and drug resistance oligo arrays. Live and lyophilized BCG were found to upregulate a similar number of genes with at least a 2-fold difference in each array. BCG, Bacillus Calmette-Guérin. genes in their basal state (Table V) Genes that were >2-fold differentially expressed compared with the control (either BCG, lyophilized BCG or both).
is a major soluble factor secreted by BCG. MptpA decreased GSTT2 expression (Fig. 3A) but exhibited no effect on TNFα or TOLLIP expression. Ag85B was previously demonstrated to increase cellular ROS (10). Ag85B increased TNFα expression, but there was no effect on TOLLIP or GSTT2 expression (Fig. 3A) . This indicates that other mycobacterial proteins may serve a role in the modulation of TNFα gene expression, as the decrease in TNFα was observed in the presence of a membrane insert.
GSTT2, TNFα and TOLLIP expression is modulated by BCG
Tice ® and Connaught. To determine if the gene expression changes observed were BCG-strain specific, MGH and J82 cells (which internalize BCG) (10) were exposed to BCG Tice ® for 2 h. Increased expression levels of GSTT2, TNFα and TOLLIP were observed in MGH cells (P<0.05; Fig. 3B ). The effects of Tice ® and Connaught on MGH cells were similar (Table V; Fig. 3B ). In the J82 cells, Connaught increased GSTT2 and TOLLIP expression (P<0.05) but had no effect on TNFα. However, Tice ® increased the expression of all 3 genes, but only TNFα was significantly increased. The differential response in J82 cells indicates that the responses of the two BCG strains are also dependent on host cell genetics. These results confirm that GSTT2, TNFα and TOLLIP are induced by the two BCG strains.
Discussion
MGH and RT4 human bladder cancer cell lines differ in the expression of several genes when unstimulated, with RT4 expressing a greater number of cytokine and chemokine genes. A limitation of the present study was that only these two cell lines were compared for the majority of the evaluations. Furthermore PCR was performed between 30-35 cycles as based on densitometry analysis of PCR products relative to cycle number; however, the PCR products were still amplifying and had not yet reached a plateau. The two cell lines responded to BCG by increasing the expression of β-actin and GAPDH. Therefore, neither gene is a suitable control gene for normalization of gene expression when analyzing BCG-induced early gene expression. Although GAPDH is regarded as a glycolytic protein, it regulates gene transcription, initiates apoptosis and is a major target for thiolation by ROS (17) . In monocytes infected with mycobacteria, increased GAPDH expression leads to increased mycobacterial survival (18) . β-actin is a cytoskeletal protein associated with cell structure, migration and the internalization of pathogens (19) . BCG-induced β-actin expression may affect any of these functions.
The genes identified may be segregated by the cells lines they are expressed in as those likely to be induced by BCG internalization and soluble factors (GSTT2, MGST2, CCL20, TNFα, CCNE1 and IL10RB) and those likely to be the result of BCG membrane interactions and/or soluble factors (MGST1, CXCL6, IL12A, CSF2, IL1β, GAPDH, β-ACTIN and TOLLIP). TNFα was not detected in RT4 cells, and this in consistent with our previous study, which demonstrated the absence of TNFα production prior and subsequent to BCG stimulation of RT4 cells (20) .
The GSTs are a family of metabolic enzymes that conjugate reduced glutathione to electrophilic compounds such as xenobiotics, carcinogens, pesticides and other chemicals, resulting in their detoxification (21) . There are ~19 members. To date, GSTP and GSTM have been implicated in the development of bladder cancer, and may possibly affect the response to therapy (22) . GSTT2 protects cells against the toxic products of oxygen and lipid peroxidation. The increased expression of GSTT2 may be due to the modulation of cellular lipid peroxidation by BCG (10) MGST2 and MGST1 are microsomal .005 vs. respective controls using one-way analysis of variance multiple comparisons with Bonferroni correction. ND indicates the RNA was not detected. Lyo, lyophilized; BCG, Bacillus Calmette-Guérin; GSTT2, glutathione S-transferase θ2; MGST, microsomal glutathione S-transferase; CSF2, colony stimulating factor 2; CCL20, C-C motif chemokine ligand 20; IL, interleukin; TNF, tumor necrosis factor; IL10RB, interleukin 10 receptor, β; TOLLIP, Toll interacting protein; CCNE1, cyclin E1.
GSTs. MGST2 is a modulator of ROS and DNA damage, while MGST1 serves a role in eicosanoid and glutathione metabolism and has previously been revealed to block the effectiveness of doxorubicin by removing the oxidative stress induced by the drug (23) . The modulation of these GSTs is consistent with the cellular ROS changes that occur following BCG internalization (6). ROS is the major means by which phagocytic cells destroy microbes (24) , and the induction of the identified genes P<0.005. Comparisons between >2 samples were performed using one-way analysis of variance with Bonferroni correction. An independent sample t-test was used for comparing between 2 samples. GSTT2, glutathione S-transferase θ 2; TNFα, tumor necrosis factor α; TOLLIP, Toll interacting protein; RPS27A, ribosomal protein S27a; MptpA, Mycobacterium protein tyrosine phosphatase A; Ag85B, antigen 85B. may serve a role in the destruction of internalized BCG. A previous study identified a single nucleotide polymorphism in GSTT2 that was correlated with recurrence following TUR in high grade bladder cancer (25) , but it has not been evaluated in patients who have received BCG immunotherapy.
TOLLIP is the inhibitory protein of Toll-like receptors (TLRs). TLR activation results in homo or hetero-dimerization of these receptors, which associate with the MyD88-IRAK-4 complex (containing IRAK-1 and IRAK-2) and triggers nuclear factor (NF)-κB activation. TOLLIP controls Myd88-mediated activation of NF-κB by: i) Binding directly to IL-1R, TLR2 and TLR4 following TLR activation; and ii) by binding to IRAK-1, inhibiting its auto-phosphorylation. A second function of TOLLIP is in protein trafficking. TOLLP binds RAC-1 and facilitates entry of uropathogenic Escherichia coli into bladder epithelial cells (26) . BCG has also been revealed to use a RAC-1-dependant pathway to enter bladder epithelial cells (5) . TOLLIP expression is associated with increased interleukin-(IL)10 production and blocking of the TGFβ pathway (27) . TOLLIP polymorphisms are associated with differential susceptibility to tuberculosis (28) , and may perhaps also modulate the response to BCG immunotherapy.
While the cytokine and chemokine genes identified exhibit well known effects on immune activation, certain genes have also have been identified to affect phagosome function. Reduction of IL10RB may reduce IL10 signaling, which is necessary to block phagosome fusion to lysosomes (29) . IL12A is also known to modulate phagosome lysosome fusion (30) . CCNE1, a regulator of the cell cycle, had a reduced expression and this would cause cell arrest. Therefore, the induction of these genes may modulate bacterial survival within cells. Consistent with this possibility, IL10RB and IL12A are reduced in MGH cells, which internalize BCG, while there is only a reduction in IL12A in RT4 cells that internalize BCG poorly. CSF2, CXCL6, CCL20 and TNFα are regulators of immune cell activation, chemotaxis and cell death. CCL20 downregulates ROS production in Mycobacterium tuberculosis (MTb)-infected monocytes (31) . It remains to be determined if the other chemokines serve a role in BCG survival. Kadhim et al (32) identified the NRAMP gene as an important regulator of BCG survival, however, it is unlikely to be the only gene that performs this function, and these results may have identified several other genes that modulate BCG survival.
Rentsch et al (12) identified that immunotherapy using BCG Tice ® and Connaught produced different outcomes in patients with bladder cancer. Tice ® has been suggested to be inferior to Connaught in inducing adaptive BCG-specific CD8 + T cell responses and recruiting T cells to the bladder (29) . This may be associated with the observation that following 72 h, Tice ® exhibits a lower survival rate compared with Connaught, and a reduced ability to induce IL8 production (13) . In the bladder cancer cell lines examined in the present study, there was a similar increase in GSTT2, TNFα and TOLLIP expression levels induced by Tice ® and Connaught cells at 2 h. Therefore, the different survival ability may be associated with bacterial genetic differences, as opposed to host factors.
Given the effects of orthovanadate and MptpA on GSTT2 expression, it is likely that a protein required for GSTT2 expression is regulated by tyrosine phosphorylation. MptpA has previously been demonstrated to modulate GSK3α activity by promoting MTb survival in macrophages (33) , and to modulate phagocytosis and actin polymerization (34) . TNFα was induced in alveolar macrophages containing MTb, and it in turn increased Ag85B expression (35) . In the present study Ag85B was able to induce TNFα expression, demonstrating an interdependent association between these 2 proteins. BCG soluble factors and whole BCG induced different effects, as observed with GSTT2 expression. Therefore, the response to BCG is a summation of the responses triggered by these two factors.
These results highlight the possibility that simply washing lyophilized BCG prior to therapy may modulate therapeutic outcomes by removing soluble factors. The genes identified in the present study may be good candidate biomarkers to evaluate outcomes in patients with bladder cancer receiving BCG immunotherapy.
